Participated · Equity · May 2025

Outcomes4Me is a Boston-based, direct-to-patient AI-driven platform that integrates clinical guidelines, genomic insights, clinical trial matching, medication and symptom tracking, and patient peer communities to help patients with cancer navigate care. The company uses patented technology and generates multimodal, patient-level datasets enriched at the drug level to deliver personalized, real-time treatment insights. Since its commercial launch in 2022, Outcomes4Me reports more than 280,000 cancer patients using its platform and an incredible revenue growth trajectory; seven of the top 10 global cancer pharmaceutical companies are among its customers. Outcomes4Me has raised $38M in total capital to date following a $21M round announced May 29, 2025. With the new funding the company plans to accelerate market penetration across additional cancer types and geographies, expand its AI capabilities, and strengthen collaborations with top-tier health systems and life sciences companies. It also intends to scale revenue streams through international expansion and outcomes-based evidence generation and real-world data insights to improve treatment and care. Outcomes4Me has developed an AI-powered patient empowerment platform that combines regulatory-grade, real-world data and patient experiences to generate insights for shared decision-making between patients and providers. The platform currently focuses on breast cancer and aims to improve care, accelerate research and achieve better outcomes. The company was co-founded in 2017 by Maya R. Said, Sc.D. (CEO) and Dr. Osama Rahma (Chief Medical Advisor); Sami Shalabi later joined as COO and brings prior Google leadership experience. Outcomes4Me plans to extend its platform beyond breast cancer to other cancers, grow its regulatory-grade dataset, and expand to more patients in Europe. The company raised $12M in a Series A to support those initiatives, indicating recent capital infusion to fund growth. Outcomes4Me offers a free mobile app and HIPAA-compliant platform that leverages artificial intelligence and machine learning to analyze medical records and provide patients with personalized, actionable information. The app is available on the Apple App Store and Google Play and surfaces resources traditionally targeted to physicians, including NCCN Guidelines and UpToDate drug information. Its technology has been applied to medical records from more than 700 institutions across the United States and Canada, and more than 10,000 breast cancer patients used the app in the past year. Co-founded by Maya R. Said, Sc.D., and Dr. Osama Rahma, the company aims to deliver timely, personalized guidance regardless of patients’ race, socioeconomic status, or location. Outcomes4Me recently added Sami Shalabi, formerly head of engineering and product development at Google, as chief operating officer. The company raised $4.7M to expand its reach to address cancers beyond breast cancer.

Participated · Seed · Feb 2023

Yobi is an all-in-one customer communications app that consolidates text, calls, CRM, and team collaboration for small businesses. Its product includes AI-powered features such as Yobi Translator and Call Sentiment Analysis to remove language barriers and surface customer sentiment. The company plans to incorporate generative AI to provide customized automation, a business assistant, call/messaging capabilities, analytics and reporting. Yobi says the $2.37M in newly raised seed capital will support operations, team expansion, product innovation and hiring AI engineers and MLOps. The funds will also be used to invest in technologies, improve activation and onboarding flows, and launch new features to improve customer experience and drive revenue growth. The company highlights strategic advisors like Dr. Edward Zuckerberg and customer endorsements citing reduced marketing costs, increased brand loyalty and more consistent customer experiences.

Participated · Equity · May 2018

Heal offers on-demand in-home and virtual primary care, telepsychology (California only), and digital monitoring, incorporating remote diagnostics such as iPhone-based EKGs and diabetic retinopathy tools. The company emphasizes continuity of care and persistent patient monitoring to make care more data-driven, timely and affordable. Heal has linked patients with more than 200,000 home visits since its 2015 launch. It has expanded treatment areas to include teletherapy for mental health and deploys hardware and digital hubs to gather remote diagnostics. Services are available in New York, New Jersey, Washington, California, Georgia, Virginia, Maryland and Washington, D.C., with planned geographic growth. Revenue or other financial operating metrics beyond visit volume were not disclosed in the article. Heal operates a technology-enabled doctor house-calls service that schedules on-demand or planned visits 8AM–8PM, 365 days a year. Since launching in March 2015, the company has delivered over 60,000 house calls and claims to have driven more than $41 million in healthcare cost savings versus traditional care alternatives. Heal says its proprietary technology lowers healthcare operating costs and bureaucracy by 65 percent and enables visits that last up to 28 minutes, compared with a national average of 13 minutes. The service is in-network with major PPO insurers and is offered as a health benefit by many large employers. Heal has expanded coverage to include Sacramento and the Inland Empire and is available to over 70 percent of California residents and most residents in Washington D.C. and Northern Virginia. The company also offers comprehensive disease management targeting the roughly 60 percent of Americans with one or more chronic illnesses. Heal plans to use new capital to pursue new markets, explore new business models, and advance its technology platform. Heal is a Los Angeles-based service that dispatches board-certified and licensed physicians for on-demand house calls and scheduled primary-care visits. Launched last year, the company already services the entire state of California and has cared for more than 10,000 patients. Patients can request an on-demand consultation within a two-hour window or schedule visits in advance; roughly 75% of repeat customers book ahead. Visits cost the price of a co-pay or a flat fee of $99, and doctors are available seven days a week from 8 a.m. to 8 p.m. Heal accepts insurance from Blue Shield of California, Anthem Blue Cross of California, Cigna Healthcare, Aetna and United Healthcare and will begin accepting Medicare payments by November. The company plans to use its new funding to develop its technology platform, increase marketing, and build out its roster of physicians as it considers expansion into markets with primary-care shortages. Heal is a California-based provider of on-demand primary healthcare services led by Dr. Renee Dua. The company offers doctors who are available in Los Angeles and San Francisco any time 8 a.m. to 8 p.m., seven days a week for services that include annual physicals, blood tests, specialist recommendations and prescription delivery. A new advanced booking option allows patients to book a doctor for the next day after hours. Doctors on Heal use medical technologies including an AliveCor ECG for near-instant heart health analysis, a CellScope otoscope to record HD-quality video inside a patient’s ear, and Electronic Medical Records to give patients easy access to their medical history. Heal secured $5M in funding and intends to use the funds to expand operations to 15 markets over the next 12 months.